Helius Medical Technologies Inc. - Proyeksi bathi mangsa ngarep HSDT
The prospects for Helius Medical (HSDT) depend on insurance companies recognizing the PoNS system as a rehabilitation standard. Projected operating profit reflects current market expectations, where the 0.00 mark characterizes this parameter. While assembly automation improves device reliability, a narrow specialization in a single product and capital constraints create certain financial risks.
Rincian analitis lan laporan data perusahaan Helius Medical Technologies Inc. (HSDT)
- rega saham lan konsensus proyeksi valuasi:
- rincian nilai pasar emiten:
- indikator kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Rasio Total Utang marang Ekuitas Helius Medical|HSDT - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Helius Medical Technologies|HSDT - Gunggung kewajiban utang perusahaan|Utang marang nilai buku Helius Medical Technologies Inc.|HSDT - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Helius Medical Technologies|Rasio cepet heliusmedical.com
- data bathi resik lan rasio valuasi:
HSDT - Penghasilan resik perusahaan|Proyeksi bathi mangsa ngarep Helius Medical|HSDT - Pangali rega marang bathi|Pangali Forward P/E Helius Medical Technologies|HSDT - Kapitalisasi marang bathi resik kanthi nimbang wutah|Pangali EV/EBITDA Helius Medical Technologies Inc.|HSDT - Bathi operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) Helius Medical Technologies|HSDT - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan heliusmedical.com|HSDT - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Helius Medical
- statistik dodolan lan pendapatan perusahaan:
Analisis wiwitan perusahaan:Helius Medical Technologies, Inc.
Selecting assets with a high margin of safety requires an analysis of forward-looking metrics. This indicator measures aggregate market expectations regarding net income, separating the fundamental trend from short-term volatility. For Helius Medical (HSDT), profit growth depends on the expansion of neurostimulators within US clinics without pursuing mergers. The trend in the company's expected earnings reflects investor confidence in the success of this strategy. Analysis based on expected company earnings helps determine the optimal entry point.
Analisis pesaing Helius Medical
BIIB (Biogen) - Proyeksi bathi mangsa ngarep|Prakiraan bathi resik NBIX (Neurocrine Biosciences, Inc.)|Proyeksi bathi mangsa ngarep RGC|Axsome Corp - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep ACAD (ACADIA Corp)|XENE: Prakiraan bathi resik|Viking Therapeutics Inc - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Supernus Pharmaceuticals, Inc.|Catalyst Pharmaceuticals Inc (CPRX) - Bathi sing dikarepake|DNLI (Denali Therapeutics Inc) - Bathi sing dikarepake|Bathi sing dikarepake Harmony Biosciences Holdings, Inc.|Bathi sing dikarepake BHVN|Bathi mangsa ngarep AMLX (Amylyx Pharmaceuticals, Inc.)|Bathi resik mangsa ngarep TRVI|Bathi sing dikarepake Praxis Precision Medicines, Inc. PRAX|Anavex Corp - Bathi sing dikarepake|CBLL: Bathi mangsa ngarep|Penghasilan resik sing dikarepake PRTA (prothena.com)|Alector, Inc. (ALEC) - Bathi sing dikarepake|Prakiraan bathi resik ANNX|Bathi sing dikarepake Omeros Corp.|Neurogene Therapeutics (NGNE) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep ACIU|VYGR (Voyager Therapeutics) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep NMRA (neumoratx.com)|SCLX: Prakiraan bathi resik|TVGN - Bathi sing dikarepake|Bathi resik sing dikarepake Alpha Cognition Inc.|CGTX: Proyeksi bathi mangsa ngarep|inhibikase.com (IKT) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Cassava Sciences Inc|ASRT - Proyeksi bathi resik|Bathi sing dikarepake Coya (COYA)|Proyeksi bathi mangsa ngarep VistaGen Therapeutics Inc (VTGN)|Ovid Therapeutics Inc. - Bathi mangsa ngarep|Prakiraan bathi perusahaan Acumen Pharmaceuticals (ABOS)|CervoMed Corporation - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan alteritytherapeutics.com ATHE|CLNN: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake PepGen Corp (PEPG)|Bathi sing dikarepake Jupiter Neurosciences, Inc.|RLMD: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep ANVS|Bathi mangsa ngarep Grace Tx GRCE|Bathi sing dikarepake Firefly Neuroscience, Inc AIFF|KLTO: Prakiraan bathi resik|NRSN - Bathi sing dikarepake|RVPH: Bathi sing dikarepake|MTVA (MetaVia Inc.) - Bathi mangsa ngarep|NeurAxis Inc. (NRXS) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Passage Bio Corp|Bathi mangsa ngarep Neuphoria Therapeutics (NEUP)|Proyeksi bathi mangsa ngarep NERV|ATHA - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ADXN (addextherapeutics.com)|Alzamend (ALZN) - Bathi resik sing dikarepake|CYCN: Bathi mangsa ngarep|Bathi resik sing dikarepake Protagenic Therapeutics Inc.|pasitheaclinics.com (KTTA) - Bathi sing dikarepake|Bathi resik sing dikarepake Cortigent Medical (CRGT)|ATXI (Avenue Therapeutics Inc) - Proyeksi bathi mangsa ngarep|BCLI (Brainstorm Cell Therapeutics Inc.) - Bathi resik mangsa ngarep|Proyeksi bathi mangsa ngarep CARA|CHRO - Bathi resik sing dikarepake|Eliem Therapeutics - Bathi mangsa ngarep|Intra-Cellular (ITCI) - Bathi resik sing dikarepake|LBPH - Bathi sing dikarepake|MRNS - Proyeksi bathi mangsa ngarep|NKGN: Proyeksi bathi mangsa ngarep|NeuroBo Pharma (NRBO) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep SAGE|Prakiraan bathi resik SNPX (Synaptogenix, Inc.)|Bathi sing dikarepake Trevena, Inc (TRVN)|VIGL (Vigil Neuroscience Inc.) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Anew Medical WENA|Bathi resik mangsa ngarep CERE (Cerevel)
